Cleared Traditional

K953971 - TRIGLYCERIDES LIQUID STABLE INCORPORATING DYNAMIC STABILISATION TECHNOLOGY

K953971 is an FDA 510(k) clearance for TRIGLYCERIDES LIQUID STABLE INCORPORATI..., manufactured by Trace America, Inc.. The device is a Class 1 Chemistry device with product code CDT cleared through the Traditional 510(k) pathway after a 226-day FDA review.

K953971 · Trace America, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1996
Decision
226d
Days
Class 1
Risk

K953971 is an FDA 510(k) clearance for the TRIGLYCERIDES LIQUID STABLE INCORPORATING DYNAMIC STABILISATION TECHNOLOGY. Classified as Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides (product code CDT), Class I - General Controls.

Submitted by Trace America, Inc. (Miami, US). The FDA issued a Cleared decision on April 5, 1996 after a review of 226 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1705 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Trace America, Inc. devices

FDA 510(k) Submission Details - K953971

510(k) Number K953971 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 23, 1995
Decision Date April 05, 1996
Days to Decision 226 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
138d slower than avg
Panel avg: 88d · This submission: 226d
Pathway characteristics
Predicate-based equivalence.

CDT Device Classification - Class 1, General Controls

Product Code CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1705
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides

All 134
Devices cleared under the same product code (CDT) and FDA review panel - the closest regulatory comparables to K953971.
TRIGLYCERIDE-SL ASSAY CATALOGUE NO. 236-60
K961281 · Diagnostic Chemicals , Ltd. · Aug 1996
TRIGLYCERIDES - INCORPORATING DYNAMIC STABILIZATION TECHNOLOGY
K961477 · Trace America, Inc. · Aug 1996
HORIZON DIAGNOSTICS TRIGLYCERIDES-GPO REAGENT
K933722 · Horizon Diagnostics, Inc. · Jun 1996
TRUE TRIGLYCERIDE
K960088 · Diagnostic Chemicals , Ltd. · Apr 1996
TRIGLYCERIDES (GLYCEROL BLANKING) REAGENT SYSTEM
K952741 · Medical Diagnostic Technologies, Inc. · Aug 1995
TRIGLYCERODES QVET
K942998 · Prisma Systems · Nov 1994